Witryna21 gru 2024 · Cost basis and return based on previous market day close. ... Why NantKwest Stock Is Skyrocketing Today. Here's Why NantKwest Skyrocketed … Witryna25 cze 2024 · EL SEGUNDO, Calif.–Jun. 25, 2024– NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced the pricing of an underwritten public offering of an aggregate of 7,410,000 shares of its common stock (3,700,000 shares at a price to the public of $9.50 per share and …
NantKwest IPO Tops High Expectations, Raises $207 Mil
Witryna9 mar 2024 · Creates Leading Immunotherapy and Cell Therapy Company. CULVER CITY & EL SEGUNDO, Calif., March 9, 2024 — ImmunityBio, Inc. and NantKwest, … WitrynaThe NantKwest, Inc. stock prediction for 2025 is currently $ 61.37, assuming that NantKwest, Inc. shares will continue growing at the average yearly rate as they did in … bank ghotala 2022
Is the Options Market Predicting a Spike in NantKwest (NK) Stock?
WitrynaNantKwest Stock Quote. NK - Stock Price, News, Charts, Message Board, Trades Home Investing Stocks USA NASDAQ NantKwest Inc (NK) Quote NK NantKwest … Witryna11 kwi 2024 · According to analysts' consensus price target of $8.60, Autolus Therapeutics has a forecasted upside of 375.1% from its current price of $1.81. Amount of Analyst Coverage Autolus Therapeutics has only been the subject of 4 research reports in the past 90 days. See Top Rated MarketRank™ Stocks Here About … Witryna- NK - Stock Price Today - Zacks NantKwest, Inc. (NK) (Delayed Data from NSDQ) $1.15 USD 0.00 (0.00%) Updated May 3, 2024 04:00 PM ET After-Market: $1.16 (%) 5:22 PM ET Add to portfolio... pneumologue a joliette